Bausch & Lomb Pharma SA
11.6 FTEBausch & Lomb Pharma reported revenue of €37.4m for the 2025 financial year (annual accounts filed with the NBB on 06 Jul 2026), with 11.6 full-time equivalents.
By total assets for 2025, Bausch & Lomb Pharma ranks among the 200 largest of the 968 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Bausch & Lomb Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +27 % Equity 0 % Total assets +14 % Headcount (avg FTE) -2 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Bausch & Lomb Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €37.4m | ||||
| Net result | 871,860 € | ||||
| Equity | 751,241 € | ||||
| Cash | 996,878 € | ||||
| EBITDA | €1.37m | ||||
| Total assets | €9.17m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Jul 2026
- Year ended 31 Dec 2024filed on 16 Jul 2025
- Year ended 31 Dec 2023filed on 10 Jul 2024
- Year ended 31 Dec 2022filed on 07 Jul 2023
- Year ended 31 Dec 2021filed on 26 Jul 2022
Bausch & Lomb Pharma's financial analysis
- Solvency8.2%sector median: 43.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Bausch & Lomb Pharma
Bausch & Lomb Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0439.621.618
- VAT number
- BE0439621618
- Peppol
- Registered · 0208:0439621618 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 19 Dec 1989
- Registered office
- 1300 Wavre
- Size
- Small · 11.6 FTE
- Latest accounts
- 2025 · filed on 06 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Bausch & Lomb Pharma (SA) has been based in Wavre since 1989, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports revenue of €37.4m, a net profit of 871,860 € and equity of 751,241 €. With 11.6 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 8.2%, below the median of its sector (43.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Bausch & Lomb Pharma
Companies in the same business, of comparable size and area, outside its group.
- V.M.D. Manufacture of pharmaceutical preparations Arendonk · balance sheet €28.5m
- Depharm Wholesale of pharmaceutical and medical goods Wavre · balance sheet €26.8m
- UPSA Belgium Wholesale of pharmaceutical and medical goods Etterbeek · balance sheet €104.2m
- Abbvie Wholesale of pharmaceutical and medical goods Wavre · balance sheet €227.4m
- Almirall Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €7.75m
- Elekta Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €13.1m
- Ceres Pharmaceuticals Wholesale of pharmaceutical and medical goods Ghent · balance sheet €9.46m
- Leo Pharma Wholesale of pharmaceutical and medical goods Lier · balance sheet €15.1m
Frequently asked questions about Bausch & Lomb Pharma
What is the revenue of Bausch & Lomb Pharma?
According to the 2025 annual accounts filed with the NBB, the revenue of Bausch & Lomb Pharma amounts to 37,404,611 €.
What is the VAT number of Bausch & Lomb Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0439621618 for Bausch & Lomb Pharma, if the company is VAT-registered. Its company number (CBE) is 0439.621.618.
Where is the registered office of Bausch & Lomb Pharma?
According to the CBE register, the registered office of Bausch & Lomb Pharma is in 1300 Wavre.
What is the equity of Bausch & Lomb Pharma?
At the close of the 2025 financial year, the equity of Bausch & Lomb Pharma amounts to 751,241 €, a solvency of 8.2% of total assets.
How many people work at Bausch & Lomb Pharma?
11.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Bausch & Lomb Pharma?
The register lists 4 active mandates at Bausch & Lomb Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Bausch & Lomb Pharma within its sector?
By total assets for 2025, Bausch & Lomb Pharma ranks among the 200 largest of the 968 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year.
The full file of Bausch & Lomb Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →